2,3-bis(3'-hydroxybenzyl)butyrolactone and Diabetes Mellitus

2,3-bis(3'-hydroxybenzyl)butyrolactone has been researched along with Diabetes Mellitus in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jones, PJ; Marinangeli, CP	1
Bonnet, F; Gilbert, R	1

Trials

1 trial(s) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Diabetes Mellitus

Article	Year
Whole and fractionated yellow pea flours reduce fasting insulin and insulin resistance in hypercholesterolaemic and overweight human subjects. The British journal of nutrition, 2011, Volume: 105, Issue:1 Topics: 4-Butyrolactone; Adiposity; Adult; Body Composition; Cardiovascular Diseases; Cross-Over Studies; Diabetes Mellitus; Fasting; Female; Flour; Humans; Hypercholesterolemia; Insulin; Insulin Resistance; Lignans; Male; Middle Aged; Overweight; Phytotherapy; Pisum sativum; Plant Preparations; Risk Factors; Seeds	2011

Article

Year

Whole and fractionated yellow pea flours reduce fasting insulin and insulin resistance in hypercholesterolaemic and overweight human subjects.

The British journal of nutrition, 2011, Volume: 105, Issue:1

Topics: 4-Butyrolactone; Adiposity; Adult; Body Composition; Cardiovascular Diseases; Cross-Over Studies; Diabetes Mellitus; Fasting; Female; Flour; Humans; Hypercholesterolemia; Insulin; Insulin Resistance; Lignans; Male; Middle Aged; Overweight; Phytotherapy; Pisum sativum; Plant Preparations; Risk Factors; Seeds

2011

Other Studies

1 other study(ies) available for 2,3-bis(3'-hydroxybenzyl)butyrolactone and Diabetes Mellitus

Article	Year
Enterolactone and coronary events. Lancet (London, England), 2000, May-06, Volume: 355, Issue:9215 Topics: 4-Butyrolactone; Coronary Disease; Diabetes Mellitus; Estrogens; Humans; Lignans; Risk Assessment	2000